GVR Report cover Veterinary Antibiotics Market Size, Share & Trends Report

Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type (Pigs, Cattle), By Dosage Form (Oral Powders, Injections), By Drug Class, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68040-298-9
  • Number of Report Pages: 258
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Veterinary Antibiotics Market Size & Trends

The global veterinary antibiotics market size was estimated at USD 5.07 billion in 2023 and is anticipated to grow at a CAGR of 3.10% from 2024 to 2030. Key factors expected to drive the market growth include the increasing prevalence of livestock diseases, rising focus on animal-only antibiotics & ionophores, and growing product launches or other initiatives undertaken by key companies. Major players in the market have shifted their focus to animal-only antibiotics to address antibiotic resistance while protecting animal health. For instance, Elanco Animal Health Incorporated offers a global antibiotic stewardship plan, which focuses on reducing shared-class antibiotics and increasing the production of animal-only antibiotics.

U.S. Veterinary Antibiotics Market size and growth rate, 2024 - 2030

The COVID-19 pandemic significantly impacted the global population as well as industries and sectors across all domains. Moreover, the animal health market was heavily impacted. The disruption of the supply chain, a drop in sales, poor demand, and operational challenges brought on by changing regulations & policies are only a few of the primary negative effects of COVID-19 on the animal health sector. The market for veterinary antibiotics was affected by the COVID-19 pandemic. Limited access to current and potential clients significantly hindered market participants' capacity to apply previously sold systems and sell new antimicrobial susceptibility testing systems during this time, which slowed down the growth in the manufacturing of antimicrobials and antibiotics.

The market is witnessing a shift toward animal-only antibiotics and ionophores. This trend is largely driven by factors such as antibiotic resistance and health & welfare concerns. The awareness about the relationship between the use of antibiotics in livestock and the development of antibiotic-resistant bacteria is growing, which may pose a threat to both animal and human health. As a result, there is a need to develop antibiotics that are exclusively used in animals to minimize the risk of cross-resistance. Moreover, animal welfare considerations are driving the shift toward traditional antibiotic alternatives. Healthier animals can often be raised without routine antibiotic use, promoting sustainable and ethical farming practices.

Moreover, few countries and key players operating in the market have already taken measures to reduce the use of antibiotics in animals. However, due to rising disease outbreaks among food-producing animals and growing demand for treating or curbing the spread of disease, antibiotics are still widely used in animals. For instance, according to The Alliance to Save Our Antibiotics, farm animals consume an estimated 66% of all antibiotics used globally. The majority of the usage is routine, allowing farm animals, primarily pigs & poultry, but occasionally cattle, to be kept in poor conditions, where diseases can spread rapidly. In addition, the chicken industry frequently uses antibiotics to treat and prevent bacterial infections & other respiratory illnesses.

Market Concentration & Characteristics

The market for veterinary antibiotics exhibits a moderate market concentration. The market growth stage is high, with an accelerating pace. One major factor propelling the market growth is the increasing incidence of livestock diseases. The rise in the incidence of livestock diseases plays a significant role in driving the market for veterinary antibiotics. Livestock diseases pose serious threats to animal health, welfare, and productivity, which can have cascading effects on food security & public health. Antibiotics are crucial tools in the veterinary sector for preventing and treating bacterial infections in animals. As livestock production intensifies to meet the growing demand for animal products, animals are often raised in crowded conditions, making them more susceptible to diseases. The World Organization for Animal Health (WOAH) has identified the most serious diseases as pullorum disease and chicken typhoid, which are caused by Salmonella enterica subspecies enterica serovar Gallinarum biovars Pullorum (bvSP) and Gallinarum (bvSG), respectively.

Veterinary Antibiotics Market Concentration & Characteristics

The market demonstrates a high degree of innovation, characterized by ongoing partnerships and collaboration between market players, product launches, and supportive initiatives. For instance, in September 2022, MSD Animal Health entered into a definitive agreement with Vence to broaden the company’s portfolio with complementary products & technologies to advance animal health & wellbeing and customer satisfaction.

Within the market, there exists a moderate-to-high level of mergers and acquisitions activity indicative of ongoing consolidation, strategic acquisitions, and partnerships among industry players. For instance, in April 2024, Virbac acquired Sasaeah to strengthen its position in the market, especially in the cattle segment. The company plans to offer manufacturing and R&D facilities in Japan and Vietnam through this acquisition.

The market experiences a moderate-to-high impact of regulations. Governments and regulatory agencies globally are enforcing strict measures to track and limit consumption in response to the growing concerns surrounding antibiotic resistance caused by the improper & excessive use of antimicrobials in livestock production. Regulations may include approval processes for antibiotic products, labeling requirements, Maximum Residue Limits (MRLs), and guidelines for responsible antibiotic use. Regulatory agencies such as the U.S. FDA in the U.S. and the European Medicines Agency (EMA) in the European Union monitor antibiotic resistance patterns in bacteria isolated from animals, food products, and the environment to assess the impact of antibiotic use on public health.

The market experiences a moderate level of product substitutes. The increasing penetration of substitutes is also a consequence of high profit margins of manufacturers. In addition, the market faces the threat of substitutes from alternative therapies, including probiotics, vaccines, phage therapy, and immunomodulators. These alternatives may offer advantages such as reduced antimicrobial resistance, targeted therapy, or enhanced animal health outcomes.

High levels of regional growth operations in the market are caused by initiatives of major competitors in the market. For example, in December 2023, Norbrook opened three state-of-the-art cleanrooms at its Nairobi manufacturing facility, following a GBP 2.3 million (USD 3.2 million) investment to enhance quality, regulatory compliance, and support local agriculture. The launch emphasized Norbrook’s role in improving animal health & food security and creating job opportunities in East Africa.

By Drug Class Insights

Tetracyclines dominated the market in 2023. Tetracyclines are a class of commonly used veterinary antibiotics. They are the first-line antibiotic drugs given to food-producing animals and are less used among companion animals such as dogs, cats, & horses. Tetracycline veterinary antibiotic drugs with brand names such as Achromycin, Sumycin, Medicycline, and Tetracyn are used to treat inflammatory skin diseases & bacterial infections in dogs. Most of these tetracycline drugs are prescribed for off-label or extra-label use in veterinary medicine. According to the Republic of Estonia Agency of Medicines, the tetracycline sales percentage in 2023 was 23.3%. According to VCA Animal Hospitals, tetracycline is an antibiotic used to treat inflammatory skin diseases in dogs and some bacterial infections (such as lupus). Although many bacteria are resistant to it, it is less frequently used to treat bacterial illnesses.

The others segment includes antibiotic drug classes such as amphenicols, cephalosporins, other quinolones, imidazole derivatives (metronidazole), nitrofuran derivatives (furazolidone), and other veterinary antimicrobials. Amphenicols are a group of compounds that include thiamphenicol, florfenicol, and chloramphenicol, which are authorized for veterinary usage. Chloramphenicol is highly effective with broad-spectrum activity; however, thiamphenicol is less effective than chloramphenicol but much safer than the latter. Cephalosporins are of four types-1st, 2nd, 3rd, and 4th generation antibiotics-and are widely used in veterinary medicine.

By Dosage Form Insights

Oral solutions dominated the market in 2023. Oral liquids or solutions are among the easiest dosage forms of veterinary antibiotics to develop and use. Most veterinary antibiotics used in food-producing animals are oral concentrated solutions dispensed directly in drinking water & later proportionated into farms’ water lines. Oral solutions offer a convenient method of administering antibiotics to animals, especially for those who are difficult to inject or handle. Moreover, owners may find administering oral solutions to their pets easier than injections, leading to better adherence to treatment regimens. Some large animal farms use automatic metering devices or medication proportions to treat a large number of animals simultaneously. According to EMA, oral antimicrobial solutions sales in over 31 EU countries were estimated to be 57% in 2020, which exhibits their wide suitability for veterinary treatments in European animal farms.

The others segment is anticipated to grow at the fastest CAGR over the forecast period. Other antibiotic dosage forms used in veterinary applications include oral pastes, tablets or capsules, and sprays. Antibiotic tablets are generally solid and are solely provided for companion animal usage. According to EMA, the overall sales of antibiotic tablets used for companion animals were estimated at 70.4 tons in 2020. France topped the list with 16.5 tons of antibiotic tablet sales. Premix products are solid dosages in which the active substance is formulated with other excipients and mixed in animal feed. Other dosage forms, such as intravaginal and intramammary infusions, are administered in food-producing animals. Intramammary infusion products are widely used to treat mastitis in cattle and are available for nonlactating & lactating cows.

Animal Type Insights

The cattle segment held the dominant revenue share of the market in 2023. Increased consumption of beef and dairy products is a major factor driving this market growth. In 2022, milk output in 27 Member States of the European Union (EU-27) is anticipated to increase by 0.2% to 150.45 million metric tons compared to 2021, according to the U.S. Department of Agriculture (USDA). Numerous private and public organizations constantly monitor these items because they must be of high quality to assure consumer safety and prevent the spread of diseases. As a result, various products are used to enhance animal immunity and produce high-quality products, including nutritional and medicinal feed additives. In addition, the growing awareness of farmers and consumers has increased the usage of such products. An increase in the use of antibiotics for disease prevention is also responsible for the growth of this segment.

Global Veterinary Antibiotics Market share and size, 2023

The others segment is anticipated to grow at the fastest CAGR over the forecast period. The segment comprises dogs, cats, horses, and small mammals. The increasing number of pet owners globally, especially in developed countries, is likely to boost the demand for veterinary antibiotics. With more households welcoming furry companions into their homes, the need for healthcare, including antibiotic treatments, rises accordingly. For instance, 91% of the pet owners in the U.S. consider pets as their family members. Furthermore, pet owners are becoming more proactive about the health and well-being of their animals, leading to an uptick in preventive veterinary care.

Regional Insights

In 2023, the North America veterinary antibiotics market accounted for the largest global share of 32.49% in the market and is expected to grow at a significant CAGR over the forecast period. The market is driven by the presence of established players and increasing demand for treatment among veterinary practices. According to Zoonoses and Public Health in 2016, zoonotic diseases are a major burden in the North America region. They are an additional threat to public health as animals are often the source of zoonotic diseases. The high prevalence of zoonotic diseases is contributing to market growth. According to the CDC, animals can transmit six out of ten known infectious diseases to humans. Furthermore, three emerging or new infectious diseases out of every four in humans come from animals.

Veterinary Antibiotics Market Trends by Region, 2024 - 2030

U.S. Veterinary Antibiotics Market Trends

The veterinary antibiotics market in the U.S. is driven by the rising requirement for antibiotics in veterinary treatments & surgeries, disease prevention, control of disease outbreaks to reduce the severity of disease in animals, and the increasing number of animal healthcare centers & practitioners. According to the American Veterinary Medical Association (AVMA) data, in 2022, a total of 124,069 veterinary practitioners were operating in the U.S. Of these, 78,717 veterinarians were employed in clinical practice.

Europe Veterinary Antibiotics Market Trends

The veterinary antibiotics market in Europe is expected to grow at a significant pace due to favorable government regulations, such as the European Union (EU) Veterinary Medicines Regulation. According to an article published by the European Public Health Alliance, stringent regulations limiting the use of veterinary antibiotics came into effect across the EU in January 2022.

The Germany veterinary antibiotics market is expected to grow owing to rising animal/pet adoptions and growing animal husbandry. According to the German livestock data, the country has the largest dairy cattle herd and the second-largest cattle population in the EU. In addition, according to the International Committee for Animal Recording (ICAR), around 50% of German farms specialize in livestock, which is anticipated to create a conducive environment for the German market.

Asia Pacific Veterinary Antibiotics Market Trends

The veterinary antibiotics market in Asia Pacific is expected to grow lucratively over the forecast period. Growth in the region can be attributed to several factors, such as the increasing adoption of pet animals, growing health concerns in animals, rising vigilance about animal health, surging livestock population, and the prevalence of animal diseases.

The India veterinary antibiotics market is expected to grow at a lucrative CAGR over the forecast period due to the rising livestock production, growing dairy industry, and increasing number of veterinary healthcare facilities. According to NCBI, in India, livestock production, particularly the dairy industry, plays a major role in communities’ food and nutritional well-being. Moreover, it supports the number of farmers and contributes to the country’s economy.

Latin America Veterinary Antibiotics Market Trends

The veterinary antibiotics market in Latin America is driven by the increasing prevalence of pet injuries and the rising sales of products. In addition, the rising livestock population and the presence of animal pharmaceutical companies are expected to drive market growth over the forecast period.

The Brazil veterinary antibiotics market is anticipated to grow due to rising mandates for vaccination to curb livestock disease outbreaks and the increasing demand for livestock-related food products. Brazil's large cattle population is also a significant factor aiding in the growth of the market. According to Agro Concept Management Ltd, Brazil had the second-largest cattle herd, accounting for 232 million heads.

Middle East & Africa Veterinary Antibiotics Market Trends

The veterinary antibiotics market in the Middle East and Africa (MEA) comprises South Africa, Saudi Arabia, and the UAE. In the MEA, the increasing demand for veterinary medicine is expected to drive market growth over the forecast period. The growing prevalence of infectious diseases in animals is predicted to improve the demand for veterinary treatments and medicines.

The South Africa veterinary antibiotics market is anticipated to grow over the forecast period. Livestock is the country’s economic backbone, as several farmers look after their animals for meat and milk to supply across the country and the globe. However, livestock are vulnerable to several infectious diseases, leading to a rise in demand for veterinary antibiotics to treat pets and livestock and prevent the disease from spreading within animals. In addition, these infectious diseases can be transmitted to humans.

Key Veterinary Antibiotics Company Insights

The market is fairly competitive due to the existence of numerous small to major market participants. Due to the existence of multiple small and large companies, the market is highly fragmented. Thus, small players face intense competition to maintain their market position. Moreover, companies are increasingly adopting various strategies, such as mergers & acquisitions, geographic expansion, and the launch of products to grow in the market. For instance, in September 2022, Merck & Co., Inc. signed a definitive agreement wherein Merck Animal Health is planning to acquire Vence, an innovator & a leader in virtual fencing for livestock management and rotational grazing, from its founders and shareholders.

Key Veterinary Antibiotics Companies:

The following are the leading companies in the veterinary antibiotics market. These companies collectively hold the largest market share and dictate industry trends.

  • Merck & Co., Inc.
  • Ceva Santé Animale.
  • Vetoquinol
  • Zoetis Services LLC
  • Boehringer Ingelheim International GmbH
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Calier
  • Bimeda, Inc
  • Prodivet pharmaceuticals SA/NV
  • Norbrook Laboratories

Recent Developments

  • In May 2023, Virbac acquired GS Partners, its long-standing distributor in the Czech Republic & Slovakia, marking its 35th subsidiary and reinforcing its presence in Central Europe. With the acquisition, Virbac aimed to enhance its ability to meet the health needs of animals in the region, particularly in the pet & ruminant sectors.

  • In June 2022, Bimeda launched two new injections: Labiprofen 150mg/mL solution for cattle, pigs, & horses and Neoskilab solution for cattle, goats, sheep, & horses.

  • In March 2021, Dechra Veterinary Products entered into an exclusive sales, marketing, and distribution agreement for three novel veterinary Hyaluronic Acid (HA) ophthalmological products with I-MED Pharma.

Veterinary Antibiotics Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 5.23 billion

Revenue forecast in 2030

USD 6.29 billion

Growth rate

CAGR of 3.10% from 2024 to 2030

Base year for estimation

2023

Actual data

2018 - 2022

Forecast period

2024 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Animal type, drug class, dosage form, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Belgium; Netherlands; Hungary; Poland; Portugal; Romania; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Merck & Co., Inc.; Ceva Santé Animale; Vetoquinol; Zoetis Services LLC; Boehringer Ingelheim International GmbH; Dechra Pharmaceuticals PLC; Elanco Animal Health Incorporated; Virbac S.A.; Calier; Bimeda, Inc; Prodivet pharmaceuticals SA/NV; Norbrook Laboratories

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Veterinary Antibiotics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global veterinary antibiotics market report based on animal type, drug class, dosage form, and region.

Global Veterinary Antibiotics Market Report Segmentation

  • Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Pigs

    • Cattle

    • Sheep & Goats

    • Poultry

    • Others

  • By Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

    • Tetracyclines

    • Penicillins

    • Sulfonamides

    • Macrolides

    • Trimethoprim

    • Lincosamides

    • Polymyxins

    • Aminoglycosides

    • Fluoroquinolones

    • Pleuromutilins

    • Other

  • By Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)

    • Oral Powders

    • Oral Solutions

    • Injections

    • Other

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

      • Netherlands

      • Belgium

      • Hungary

      • Poland

      • Portugal

      • Romania

    • Asia Pacific

      • Japan

      • India

      • China

      • South Korea

      • Australia

    • Latin America

      • Brazil

      • Argentina

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.